Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels

Shirley Uitte de Willige(Leiden University Medical Center), Rogier M. Bertina(Leiden University Medical Center), Frits R. Rosendaal(Leiden University Medical Center), Jeanine J. Houwing‐Duistermaat(Leiden University Medical Center), Marieke C. Visser(Hermes Arzneimittel (Germany)), Hans L. Vos(Leiden University Medical Center)
Blood
September 7, 2005
10.1182/blood-2005-05-2180
Cited by 247

Related Papers

Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
|PubMed|2001|803